Clinical Research
AVEO and HiberCell Partner to Develop First-in-Human PERK Inhibitor for Kidney Cancer
First-in-Human PERK inhibitor (HC-5404) to be developed in combination with AVEO's FOTIVDA® (tivozanib) for RCC – – AVEO...
November 05, 2025 | News
Alpha Fusion Initiates Phase I Trial of Alpha-Emitting Radiopharmaceutical af-001 for Differentiated Thyroid Cancer
– Aiming to establish af-001 as a new therapeutic option for radioactive iodine (RAI)-naïve patients with differentiated thyroid cancer – ...
November 03, 2025 | News
Novartis Review Reveals Fear of Recurrence as a Major Unmet Need in Breast Cancer Survivorship Across Asia Pacific and the Middle East
A new targeted literature review finds the fear of recurrence a major unmet need in breast cancer survivorship, often found to affect at least two in fiv...
October 31, 2025 | Report
ICHORtec Expands Collaboration with Johns Hopkins to Advance Quantum-Driven Precision in CRISPR Gene Editing
ICHORtec GmbH is pleased to announce an expanded research collaboration with the laboratory of Professor Gregory A. Newb...
October 30, 2025 | News
SK pharmteco and LOTTE BIOLOGICS Join Forces to Build Fully Integrated Global ADC CDMO Platform
Two global CDMO leaders have joined forces to strengthen their presence in the rapidly growing antibody-drug conjugate (ADC) market. The collaboration w...
October 30, 2025 | News
Myrio Therapeutics Partners with University of Pennsylvania and NYU Langone to Advance Next-Generation T Cell Immunotherapies
Myrio Therapeutics, the University of Pennsylvania Perelman School of Medicine, and NYU Langone Health have entered a research collaboration to...
October 29, 2025 | News
Thermo Fisher Expands Bengaluru R&D Centre to Advance Antibody Innovation and Strengthen India’s Life Sciences Ecosystem
Thermo Fisher Scientific has inaugurated the expanded Research and Development (R&D) Centre of Excellence in Bengaluru, marking a major step in advanci...
October 28, 2025 | News
OncoC4 and BioNTech’s Gotistobart Receives Breakthrough Therapy Designation in China for Squamous Non-Small Cell Lung Cancer
Designation granted for gotistobart (BNT316/ONC392) for the treatment of patients with squamous non-small cell lung cancer (sqNSCLC), an aggressive subtype...
October 28, 2025 | News
Teijin Pharma Licenses Rheumatoid Arthritis Drug Candidate TCK-276 to UK-Based Elevara Medicines in Global Agreement
Teijin Pharma Limited, the core company of the Teijin Group’s healthcare business, announced that has entered into an exclusive ...
October 24, 2025 | News
BioMed X and Daiichi Sankyo Launch New Research Team in Heidelberg to Advance Multispecific Biologics for Solid Tumour Immunotherapy
BioMed X, a leading innovation hub for pharma,announced the start of a new research team at its Heidelberg institute for multispecific biologics in th...
October 24, 2025 | News
Syngene Strengthens India’s ADC Ecosystem With New GMP Bioconjugation Suite in Bengaluru
Syngene International, a global contract research, development and manufacturing organization (CRDMO), is adding a GMP bioconjugation suite at its commerci...
October 24, 2025 | News
Takeda and Innovent Biologics Announce Global Collaboration for Two Late-Stage Oncology Programs Valued at Over US$1.2 Billion
Takeda to Receive Rights to Two Next-Generation Late-Stage Investigational Medicines, Worldwide Outside of Greater China, and an Exclusive Option to Li...
October 23, 2025 | News
SunRock Biopharma and Chime Biologics Partner to Advance Novel Anti-CCR9 Antibody Therapy for Inflammatory Bowel Disease
SunRock Biopharma, a biotechnology company focused on developing next-generation therapeutic antibodies, and Chime Biologics, a global leading contrac...
October 22, 2025 | News
Samsung Bioepis and Phrontline Partner to Develop Next-Generation Bispecific, Dual-Payload ADC Therapies for Solid Tumours
Samsung Bioepis and Phrontline will co-develop two investigational antibody-drug conjugate (ADC) assets directed against targets expressed in a broad r...
October 22, 2025 | News
Most Read
- The New AI Gold Rush: Western Pharma’s Billion-Dollar Bet on Chinese Biotech
- Top 25 Biotech & Biopharma Leaders in Sustainable Innovation, 2025
- China’s Biopharma Dealmaking Surges in H1 2025, Driven by Record Licensing and Oncology Focus
- Chikungunya in China: How a “Forgotten” Arbovirus Found the Perfect Storm
- How Innovation Gaps in Biopharma Raise New Safety Concerns
- Smart Implants and the Future of Musculoskeletal Injury Treatment
- How Ethical Gaps in Psychiatry Could Undermine Biopharma Progress
- The Evolving Landscape of Women’s Health Innovation in the Asia-Pacific
- Using NLP-Driven Decision Support in Emergency Health Assistance
- Taiwan Steps Into the Global Spotlight With a New Cancer Therapy
- The Role of Unique Device Identification (UDI) in Tracing Medical Device Safety
- The Importance of a Patient’s Mental Health During Clinical Trials
Bio Jobs
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
